NasdaqGS:BNTXBiotechs
BioNTech (NasdaqGS:BNTX): Reassessing Valuation After a Recent 9% Share Price Slide
BioNTech (NasdaqGS:BNTX) has quietly slipped about 9% over the past month, extending a choppy downtrend this year. With shares now near 93 dollars, investors are reassessing what the post pandemic pipeline really justifies.
See our latest analysis for BioNTech.
That recent slide sits on top of a tougher backdrop, with the year to date share price return down sharply and the one year total shareholder return also negative, suggesting momentum is still fading as investors wait for clearer proof...